12 results
6-K
EX-99.4
PHVS
Pharvaris NV
1 Jun 23
Pharvaris Announces Annual Meeting of Shareholders
6:51am
are directly or indirectly directed to the formulation of our PHVS719 product candidate and its use in chronic or prophylactic treatment of HAE … are recommended for patients on chronic androgen therapy.
We are also aware of a number of HAE therapies in clinical development. Currently
20-F
2020 FY
PHVS
Pharvaris NV
29 Apr 21
Annual report (foreign)
4:18pm
lipid profiles, and biennial hepatic ultrasound are recommended for patients on chronic androgen therapy.
We are also aware of a number of HAE therapies … or that it is intended for the diagnosis, prevention or treatment of a life-threatening, seriously debilitating or serious and chronic condition in the European
424B4
pt15ck
8 Feb 21
Prospectus supplement with pricing info
4:34pm
F-1/A
jc8 p235h1uvl
1 Feb 21
Registration statement (foreign) (amended)
6:26am
F-1/A
2haxa4 7qrd
22 Jan 21
Registration statement (foreign) (amended)
5:25pm
F-1
l0h1gk404w4n
15 Jan 21
Registration statement (foreign)
4:31pm
DRS/A
lf552
11 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
l600ifdqmn84i4lb
18 Dec 20
Draft registration statement (amended)
12:00am
DRS
w1pnj3h o0m
12 Nov 20
Draft registration statement
12:00am
- Prev
- 1
- Next